Related Experiment Video
Updated: Jun 21, 2026

07:51
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
Published on: May 21, 2018
Enlistment of combinatorial techniques in drug development
1Molecumetics Ltd, Bellevue, WA 98005, USA.
Summary
Combinatorial chemistry accelerates drug discovery by creating diverse molecular libraries. This review highlights computational methods and cyclic scaffolds for efficient drug optimization.
Area of Science:
- Medicinal Chemistry
- Computational Chemistry
- Organic Chemistry
Background:
- Combinatorial chemistry enables the generation of large non-peptide and non-oligonucleotide libraries.
- High-throughput screening and data management are crucial for effective drug discovery.
- The review focuses on computational chemistry, solid-phase organic chemistry, and downstream analysis.
Purpose of the Study:
- To review computational aspects of combinatorial library design.
- To emphasize the use of cyclic scaffolds for focused libraries.
- To discuss optimization strategies in drug discovery.
Main Methods:
- Computational chemistry for library design.
- Solid-phase organic chemistry for library generation.
- Downstream analysis techniques.
Main Results:
- Combinatorial chemistry significantly impacts drug discovery efforts.
- Computational approaches enhance library design.
- Cyclic scaffolds are valuable for focused library optimization.
Conclusions:
- Effective drug discovery relies on integrated approaches including library design, screening, and data management.
- Computational chemistry plays a pivotal role in designing targeted libraries.
- The strategic use of cyclic scaffolds can accelerate the optimization of drug candidates.
Related Concept Videos
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
